Armstrong Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Hold
360
0.01% 319
2026
Q1
$127K Hold
360
0.01% 292
2025
Q4
$118K Hold
360
0.01% 290
2025
Q3
$102K Sell
360
-83
-19% -$24.1K 0.01% 303
2025
Q2
$124K Sell
443
-68
-13% -$19.3K 0.01% 261
2025
Q1
$133K Hold
511
0.01% 236
2024
Q4
$133K Buy
511
+1
+0.2% +$297 0.01% 236
2024
Q3
$164K Hold
510
0.01% 209
2024
Q2
$159K Buy
510
+58
+13% +$17K 0.01% 209
2024
Q1
$130K Hold
452
0.01% 217
2023
Q4
$130K Sell
452
-20
-4% -$5.45K 0.01% 217
2023
Q3
$127K Buy
472
+40
+9% +$9.98K 0.01% 205
2023
Q2
$95.9K Buy
432
+35
+9% +$8.12K 0.01% 244
2023
Q1
$96K Hold
397
0.01% 245
2022
Q4
$104K Buy
+397
New +$106K 0.01% 235

Other funds holding AMGN

Armstrong Advisory Group's AMGN Position: Q2 2026 in Review

Armstrong Advisory Group held its Amgen (AMGN) position steady in Q2 2026 at 360 shares worth $130K. The position accounts for 0.01% of the portfolio, ranked #319.

Armstrong Advisory Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $164K in Q3 2024. 748 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Armstrong Advisory Group held 360 shares of Amgen worth $130K as of Q2 2026.
  • Armstrong Advisory Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #319 holding.
  • Armstrong Advisory Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Amgen position peaked at $164K in Q3 2024.
  • 748 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.